Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases. As gut microbial imbalances and maladaptive host responses have been impli...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Mette Simone Aae, Holm, Jacob Bak, Pallejà, Albert, Wismann, Pernille, Fabricius, Katrine, Rigbolt, Kristoffer, Mikkelsen, Martin, Sommer, Morten, Jelsing, Jacob, Nielsen, Henrik Bjørn, Vrang, Niels, Hansen, Henrik H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821799/
https://www.ncbi.nlm.nih.gov/pubmed/31666597
http://dx.doi.org/10.1038/s41598-019-52103-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821799/
https://www.ncbi.nlm.nih.gov/pubmed/31666597
http://dx.doi.org/10.1038/s41598-019-52103-x

Ejemplares similares